OTB-658   Click here for help

GtoPdb Ligand ID: 13548

Synonyms: compound 19c [PMID: 32666789]
Compound class: Synthetic organic
Comment: OTB-658 is a prelinical candidate belonging to the oxazolidinone class of antibacterial compounds. It was discovered using a structure-activity aided strategy to identify novel oxazolidinones that retain activity against Mycobacterium tuberculosis but have reduced toxicity [4].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 96.41
Molecular weight 381.42
XLogP 1.63
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=O)NC[C@H]1[C@]2([H])COC3=CC(=C(C=C3N2C(=O)O1)F)N4CCSCC4
Isomeric SMILES CC(NC[C@@H]1OC(N2C3=CC(F)=C(N4CCSCC4)C=C3OC[C@]21[H])=O)=O
InChI InChI=1S/C17H20FN3O4S/c1-10(22)19-8-16-14-9-24-15-7-12(20-2-4-26-5-3-20)11(18)6-13(15)21(14)17(23)25-16/h6-7,14,16H,2-5,8-9H2,1H3,(H,19,22)/t14-,16-/m0/s1
InChI Key WZAVWVAEARSISR-HOCLYGCPSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
It has been reported that OTB-658 was approved for clinical trials by the Chinese National Medical Products Administration in 2020, and that a Phase 1 clinical trial has begun [3]. However, we have been unable to find the registration for this clinical trial.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The antibacterial MMOA of oxazolidinones is inhibition of protein synthesis by blocking function of the bacterial 50S ribosomal subunit [2].